IMARC Group has recently released a new research study titled “Amniotic Membrane Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.
How big is the amniotic membrane market?
The global amniotic membrane market size reached US$ 1.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.4 Billion by 2028, exhibiting a growth rate (CAGR) of 9% during 2023-2028.
Industry Overview:
The amniotic membrane is the innermost layer of the placenta, which lines the amniotic cavity and encloses the fetus during pregnancy. Composed of multiple layers including an epithelial layer, a basement membrane, and an avascular connective tissue layer, it is a unique tissue with various biological properties. The membrane has a range of medical applications due to its natural abilities for wound healing, anti-inflammation, and tissue regeneration.
In medicine, amniotic membranes are commonly used in surgical procedures such as ophthalmic surgery, wound care, and reconstructive surgery. They are harvested either from planned cesarean section deliveries or cadaveric tissue and are generally processed and sterilized before use. The unique qualities of the amniotic membrane make it a valuable resource in regenerative medicine.
Request to Get the Sample Report: https://www.imarcgroup.com/amniotic-membrane-market/requestsample
Amniotic Membrane Market Trends and Growth Drivers:
The increasing number of age-related diseases and conditions that require surgical interventions represents one of the key factors driving the growth of the market across the globe. Innovations in tissue engineering and preservation techniques have improved the quality and shelf-life of amniotic membranes, thus making them more attractive for medical use. The innate ability of amniotic membranes to support wound healing, reduce inflammation, and promote tissue regeneration is a significant driver for its use in medical treatments. The versatility of amniotic membranes in treating various conditions like ocular diseases, skin ulcers, and surgical wounds is widening its scope of application, which is propelling the market growth.
The market is also driven by the rising public awareness about the benefits of amniotic membrane treatment encourages higher adoption rates. In line with this, the increasing investments in healthcare facilities, especially in developing nations, are creating opportunities for the adoption of advanced treatments involving amniotic membranes.
Who are the key players operating in the industry?
The report covers the major market players including:
Amniotic Membrane Key Companies:
- Amnio Technology LLC
- Amniox Medical Inc. (TissueTech Inc.)
- Genesis Biologics
- Human Regenerative Technologies LLC
- Integra LifeSciences Holdings Corporation
- Katena Products Inc.
- MiMedx Group
- Next Biosciences
- Skye Biologics Holdings LLC
- Smith & Nephew plc
- Surgenex LLC
- Ventris Medical LLC
- Wright Medical Group N.V. (Stryker B.V.)
Speak To An Analyst: https://www.imarcgroup.com/request?type=report&id=4503&flag=C
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Product:
- Cryopreserved Amniotic Membrane
- Lyophilization Amniotic Membrane
Breakup by Application:
- Surgical Wounds
- Ophthalmology
- Others
Breakup by End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialized Clinics
- Research Centers and Laboratory
Breakup by Region:
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States
Website: https://www.imarcgroup.com
